Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine EdurantSelf-StudyPrevention of HIV
Apply Evidence-Based Recommendations for the Prevention of HIV Transmission
Sign In or Register to get started
Apply Evidence-Based Recommendations for the Prevention of HIV Transmission
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 1 Overview
Preventing Perinatal HIV Transmission - 0%Topic 1
OverviewActivities - 0%Topic 2
HIV Testing During PregnancyActivities - 0%Topic 3
Antepartum ManagementActivities - 0%Topic 4
Intrapartum ManagementActivities - 0%Topic 5
Acute HIV in Pregnancy and in the Postpartum PeriodActivities - 0%Topic 6
Management of the Infant Exposed to HIVActivities - 0%Topic 7
Postpartum Follow-Up for Women with HIVActivities - 0%Topic 8
Summary PointsActivities - Preventing Perinatal HIV Transmission CE Quiz
Preventing Perinatal HIV Transmission Overview
About this Lesson
Last Updated: February 3rd, 2025
CNE/CME Continuing Education
This lesson qualifies for:
View CE Notices
- 1.5 CME AMA PRA Category 1 Credits™, or
- 1.5 CNE contact hours and 1.5 CE contact hours (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: July 1st, 2017
CNE and CME Review: September 1st, 2023
CNE and CME Expiration: August 31st, 2026 (3rd Edition)
View CE Notices
Steps to Acquire CE for this Lesson:
1
Quiz
Score 80%+
2
Give Feedback
Complete survey
3
Print CE Certificate
Obtain proof of CE3rd Edition
This is a substantial revision of the original Lesson. The previous edition was titled Preventing Perinatal HIV Transmission and available until September 1st, 2023.
Learning Objectives
- Explain the mechanisms of perinatal HIV transmission and interventions to reduce the risks of perinatal HIV transmission
- List preferred initial antiretroviral regimens for pregnant women with HIV
- Discuss indications for use of intravenous zidovudine and cesarean section for pregnant women with HIV
- Describe recommended antiretroviral prophylaxis for infants born to pregnant women with HIV
- Summarize recommendations for initial management of infants exposed to HIV, including HIV diagnostic testing and monitoring
Lesson Contributors
Authors
Aley G. Kalapila, MD, PhD
Aley G. Kalapila, MD, PhD
Associate Professor of Medicine
Division of Infectious Diseases
Emory University School of Medicine
Grady Health System
Associate Professor of Medicine
Division of Infectious Diseases
Emory University School of Medicine
Grady Health System
Disclosures:
None
Reviewers
David H. Spach, MD
David H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures:
None
Lesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
Question Bank
Interactive board-review style questions about Epidemiology of HIV.
CNE/CME CME+MOC credits and CNE contact hours available.